Outcomes of Video-assisted Minimally Invasive Cardiac Myxoma Resection

Bianchi, Giacomo; Margaryan, Rafik; Kallushi, Enkel; Cerillo, Alfredo Giuseppe; Farneti, Pier Andrea; Pucci, Angela; Solinas, Marco

doi:10.1016/j.hlc.2017.11.010

Cited by 15 publications

(24 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A retrospective study from the Mayo Clinic spanning over 50 years reported a recurrence rate of 5.6% with a MS approach. 22 Similarly, Keeling et al 23 reported a rate of 2% and in a prospective single cohort series of patients treated with a minimally invasive approach, Bianchi et al 24 In our meta-analysis, there were no conversions to sternotomy and the rate of reopening for bleeding was similar between the two groups (safety end-point). The presence of a right atrial tumor has been reported as possible contraindication for a minimally invasive approach due to fragmentation during cannulation procedures.…”

Section: Meta-regressionsupporting

confidence: 57%

See 1 more Smart Citation

Minimally invasive approaches to primary cardiac tumors: A systematic review and meta‐analysis

Moscarelli¹,

Rahouma

Nasso³

et al. 2020

J Card Surg

View full text Add to dashboard Cite

Objective Cardiac tumors are rare conditions. The vast majority of them are benign yet they may lead to serious complications. Complete surgical resection is the gold standard treatment and should be performed as soon as the diagnosis is made. Median sternotomy (MS) is the standard approach and provides excellent early outcomes and durable results at follow‐up. However, minimally invasive (MI) is gaining popularity and its role in the treatment of cardiac tumors needs further clarification. Methods A systematic literature review identified 12 candidate studies; of these, 11 met the meta‐analysis criteria. We analyzed outcomes of 653 subjects (294 MI and 359 MS) with random effects modeling. Each study was assessed for heterogeneity. The primary endpoints were mortality at follow‐up and tumor relapse. Secondary endpoints included relevant intraoperative and postoperative outcomes; tumor size was also considered. Results There were no significant between‐group differences in terms of late mortality (incidence rate ratio [IRR]: MI vs. MS, 0.98 [95% confidence interval [CI]: 0.25–3.82], p = .98). Few relapses (IRR: 1.13; CI: 0.26–4.88; p = .87) and redo surgery (IRR: 1.92; 95% CI: 0.39–9.53; p = .42) were observed in both groups; MI approach resulted in prolonged operation time but that did not influence the clinical outcomes. Tumor size did not significantly differ between groups. Conclusion Both MI and MS are associated with excellent early and late outcomes with acceptable survival rate and low incidence of recurrences. This study confirms that cardiac tumor may be approached safely and radically with a MI approach.

show abstract

Section: Meta-regressionsupporting

confidence: 57%

“…A retrospective study from the Mayo Clinic spanning over 50 years reported a recurrence rate of 5.6% with a MS approach 22 . Similarly, Keeling et al 23 reported a rate of 2% and in a prospective single cohort series of patients treated with a minimally invasive approach, Bianchi et al 24 reported an incidence of recurrence of 3.3%.…”

Section: Discussionmentioning

confidence: 98%

Minimally invasive approaches to primary cardiac tumors: A systematic review and meta‐analysis

Moscarelli¹,

Rahouma

Nasso³

et al. 2020

J Card Surg

View full text Add to dashboard Cite

show abstract

“…The minimally invasive cardiac surgical procedures for cardiac tumours, has gained popularity over conventional surgery for various reasons mainly patient satisfaction, quick post-operative recovery, decreased length of hospital stay and decreased cost (7)(8)(9) with oncological clearance comparable to median sternotomy approach (10). Despite primary cardiac tumours, for which surgical resection are indicated, are rare (11), it is usually a relatively straight forward procedure for surgeons with well-established minimally invasive practice because they extrapolate the same setup for minimal access valve surgeries where the right and left atria are accessed through right mini-thoracotomy as is mitral and tricuspid setup (12,13) and the aortic valve is accessed through right anterior thoracotomy (ART) (14).…”

Section: Introductionmentioning

confidence: 99%

Minimally invasive resection of benign cardiac tumors

Kenawy¹,

Abdelbar²,

Zacharias³

2021

J Thorac Dis

View full text Add to dashboard Cite

Primary cardiac tumours for which surgical resection is the main stay of treatment are rare and present both diagnostic and management challenges. The majority of patients are asymptomatic and one third of those who have symptoms present with vague constitutional symptoms which further complicates the process of early diagnosis. The current state-of-the art multi-modality imaging, routine use of intraoperative transoesophageal echocardiogram (TOE) in most cardiac centres and the tremendous advances of endoscopic adjuncts greatly enhances both the diagnosis and management of those group of patients. The surgical burden of median sternotomy and the contemporary trend towards less invasive surgery urged the necessity for adopting minimally invasive surgery in general and cardiac tumours are no exception. Despite the rarity of theses tumours, minimally invasive resection is successful in the hands of experienced minimally invasive surgeons who employ the same minimal access valve surgery platform to access the tumours in various cardiac chambers and valves with no compromise to the oncological clearance and hence achieve the benefits of minimally invasive surgery without compromising long term outcomes.

show abstract

“…2,16 Cardiac myxoma was observed in all age groups, and the mean range of age was 42 to 66 years. [17][18] It was rarely reported in younger patients compared with those older, and usually as a familial form of CM. Most commonly, CM was located in the left atrium, whereas unusual locations were detected in the right atrium in 0.7% to 7.5% of patients, in the right ventricle in 0.7% Clinical presentation Clinical presentation and signs observed in patients with CM depend on the location and mobility of the tumor.…”

mentioning

confidence: 99%

“…Minimally invasive or robotic CM resection was reported in small patient samples in the last years. 17,[33][34][35] The scope of minimally invasive approach is the same as that of conventional open surgery, namely, the radical resection of CM with the affected surrounding structures. A double--lumen endotracheal tube is used for patient intubation.…”

mentioning

confidence: 99%

Current challenges in the diagnosis and treatment of cardiac myxoma

Samanidis¹,

Khoury²,

Balanika³

et al. 2020

Kardiol Pol

View full text Add to dashboard Cite

Methods This review is based on research of the current literature regarding the epidemiology of CM, its clinical presentation, diagnosis, and treatment. The PubMed database was searched for eligible studies and the search was restricted to the years 2000 to 2019. The search term was "cardiac myxoma" and we included observational or retrospective studies with large samples of patients who were treated for CM only. In addition, the data of interest to the present review were long-term follow-up, the recurrence rate during follow-up, and the survival rate after CM resection. Additionally, we looked for studies on novel surgical techniques for CM resection and those describing unusual CM location or clinical presentation. The primary source for data extraction were 24 articles from 15 countries, which reported on a total of 2205 patients with CM (TABLE 1). 1-24 We included studies from Europe, North and South America,

show abstract

Outcomes of Video-assisted Minimally Invasive Cardiac Myxoma Resection

Cited by 15 publications

References 24 publications

Minimally invasive approaches to primary cardiac tumors: A systematic review and meta‐analysis

Minimally invasive approaches to primary cardiac tumors: A systematic review and meta‐analysis

Minimally invasive resection of benign cardiac tumors

Current challenges in the diagnosis and treatment of cardiac myxoma

Contact Info

Product

Resources

About